ArticlePeerJ2026
A machine learning-based risk prediction model for Hospitalized patients with deep vein thrombosis.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep vein thrombosis (DVT) is a common thrombotic condition with substantial morbidity when not identified early. Machine learning (ML)-based predictive models may improve early identification of patients at high risk for DVT, but few clinically applicable early-risk models exist. Objectives: To develop and internally validate a ML model using routinely available clinical and laboratory indicators for early risk prediction of DVT, and to identify the most influential predictors using model explainability techniques. Methods: We retrospectively analyzed clinical data from 231 patients evaluated at the Fifth Affiliated Hospital of Southern Medical University between January 2017 and June 2024. Patients were labeled as DVT occurrence ( Results: LASSO selected seven predictors: hemoglobin, platelet count, leukocyte count, fibrinogen, prothrombin time, D-dimer (DD), and glucose. The Random Forest model showed the best discrimination (test-set AUC = 0.874), with favorable accuracy, recall, and F1 compared with other classifiers (detailed metrics reported in the manuscript). In the RF model, D-dimer had the highest feature-importance contribution; SHAP analysis confirmed DD as the dominant risk driver and characterized the directions and relative effects of other features. Conclusions: We developed an internally validated ML model for early DVT risk prediction using seven routine clinical variables; Random Forest achieved the best performance and identified D-dimer as the most influential predictor. This model may support earlier identification and intervention for patients at risk of DVT, pending external validation and prospective evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.